Rowena Delos Santos

Medicine & Life Sciences

1. Transplants 100%
2. Kidney 87%
3. Transplant Recipients 74%
4. Kidney Transplantation 58%
5. Tacrolimus 31%
6. Allografts 30%
7. Autoantigens 27%
8. Transplantation 24%
9. Pancreas Transplantation 20%
10. Chronic Renal Insufficiency 19%
11. HLA Antigens 18%
12. Antibodies 18%
13. eculizumab 18%
14. Organ Transplantation 17%
15. Sitagliptin Phosphate 17%
16. Immunoglobulin Class Switching 17%
17. Calcineurin Inhibitors 17%
18. Pancreas 17%
19. Hydroxymethylglutaryl CoA Reductases 16%
20. Thrombotic Microangiopathies 16%
21. Chimeric Antigen Receptors 16%
22. Solitary Kidney 16%
23. Chronic Kidney Failure 15%
24. Acute Kidney Injury 14%
25. Hyperparathyroidism 14%
26. Lymphoproliferative Disorders 14%
27. Immunoglobulin Isotypes 14%
28. Manuscripts 14%
29. Cytomegalovirus 14%
30. Bone Diseases 13%
31. Rituximab 13%
32. Retrospective Studies 13%
33. Dialysis 13%
34. Glomerulonephritis 13%
35. Graft vs Host Disease 12%
36. Population 12%
37. Vimentin 12%
38. thymoglobulin 12%
39. Diabetes Mellitus 12%
40. Cardiomyopathies 11%
41. Interleukin-17 11%
42. Interleukin-10 11%
43. Cell- and Tissue-Based Therapy 11%
44. Haplotypes 11%
45. Tissue and Organ Procurement 11%
46. Coronary Disease 10%
47. Therapeutics 10%
48. Renal Dialysis 10%
49. Safety 9%
50. Immunosuppressive Agents 9%